Variation in Dicer Gene Is Associated with Increased Survival in T-Cell Lymphoma

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Li, Xi ^a   Tian, Xiaobo ^a   Zhang, Bo ^a   Zhang, Yanqi ^a   Chen, Jieping ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; CYCLOPHOSPHAMIDE; DICER; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BAFF GENE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; CHILD; CHINESE; DICER GENE; FEMALE; GENE; GENE FUNCTION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAZARD RATIO; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL PREDICTION; T CELL LYMPHOMA;

AGED; ALLELES; B-CELL ACTIVATING FACTOR; DEAD-BOX RNA HELICASES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HETEROZYGOTE; HUMANS; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RIBONUCLEASE III; SURVIVAL ANALYSIS;

EID: 84870889602     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051640     Document Type: Article

References (45)

1. Kwong YL, Anderson BO, Advani R, Kim WS, Levine AM, et al. (2009) Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 10: 1093-1101.
2. Yang QP, Zhang WY, Yu JB, Zhao S, Xu H, et al. (2011) Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol 6: 77.
3. The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329: 987-994.
4. The Non-Hodgkin's Lymphoma Classification Project (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 89: 3909-3918.
5. Piccaluga PP, Agostinelli C, Gazzola A, Mannu C, Bacci F, et al. (2010) Prognostic markers in peripheral T-cell lymphoma. Curr Hematol Malig Rep 5: 222-228.
6. Suzumiya J, Ohshima K, Tamura K, Karube K, Uike N, et al. (2009) The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project. Ann Oncol 20: 715-721.
7. de Haas EC, Zwart N, Meijer C, Nuver J, Boezen HM, et al. (2008) Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer. J Clin Oncol 26: 1817-1823.
8. Nuckel H, Frey UH, Bau M, Sellmann L, Stanelle J, et al. (2007) Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia. Blood 109: 290-297.
9. Kim JG, Chae YS, Sohn SK, Cho YY, Moon JH, et al. (2008) Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res 14: 62-66.
10. Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, et al. (2012) Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481: 506-510.
11. Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, et al. (2012) The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481: 157-163.
12. Costa FF, Bischof JM, Vanin EF, Lulla RR, Wang M, et al. (2011) Identification of MicroRNAs as Potential Prognostic Markers in Ependymoma. PLoS One 6: e25114.
13. Campayo M, Navarro A, Vinolas N, Tejero R, Munoz C, et al. (2011) A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma. PLoS One 6: e22509.
14. Ibarrola-Villava M, Fernandez LP, Alonso S, Boyano MD, Pena-Chilet M, et al. (2011) A customized pigmentation SNP array identifies a novel SNP associated with melanoma predisposition in the SLC45A2 gene. PLoS One 6: e19271.
15. Zhai K, Tian X, Wu C, Lu N, Chang J, et al. (2012) Cytokine BAFF Gene Variation Is Associated with Survival of Patients with T-cell Lymphomas. Clin Cancer Res 18: 2250-2256.
16. Bernstein E, Caudy AA, Hammond SM, Hannon GJ, (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409: 363-366.
17. McManus MT, Sharp PA, (2002) Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 3: 737-747.
18. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM, (2006) MicroRNA expression and function in cancer. Trends Mol Med 12: 580-587.
19. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
20. Kumar MS, Pester RE, Chen CY, Lane K, Chin C, et al. (2009) Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev 23: 2700-2704.
21. Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, et al. (2008) Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 359: 2641-2650.
22. Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, et al. (2005) Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 96: 111-115.
23. Guo X, Liao Q, Chen P, Li X, Xiong W, et al. (2012) The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma. J Cancer Res Clin Oncol 138: 49-56.
24. Clague J, Lippman SM, Yang H, Hildebrandt MA, Ye Y, et al. (2010) Genetic variation in MicroRNA genes and risk of oral premalignant lesions. Mol Carcinog 49: 183-189.
25. Persson H, Kvist A, Rego N, Staaf J, Vallon-Christersson J, et al. (2011) Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene. Cancer Res 71: 78-86.
26. Friedlander MR, Mackowiak SD, Li N, Chen W, Rajewsky N, (2012) miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res 40: 37-52.
27. Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG, et al. (2010) Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis 31: 1805-1812.
28. Valencak J, Schmid K, Trautinger F, Wallnofer W, Muellauer L, et al. (2011) High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas. J Dermatol Sci 64: 185-190.
29. van Kester MS, Ballabio E, Benner MF, Chen XH, Saunders NJ, et al. (2011) miRNA expression profiling of mycosis fungoides. Mol Oncol 5: 273-280.
30. Merkel O, Hamacher F, Laimer D, Sifft E, Trajanoski Z, et al. (2010) Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma. Proc Natl Acad Sci U S A 107: 16228-16233.
31. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M, (1971) Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31: 1860-1861.
32. Zhang HP, Singer B (2010) Recursive Partitioning and Applications. Springer, New York.
33. Rizvi MA, Evens AM, Tallman MS, Nelson BP, Rosen ST, (2006) T-cell non-Hodgkin lymphoma. Blood 107: 1255-1264.
34. Landi MT, Zhao Y, Rotunno M, Koshiol J, Liu H, et al. (2010) MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res 16: 430-441.
35. Wulfken LM, Moritz R, Ohlmann C, Holdenrieder S, Jung V, et al. (2011) MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. PLoS One 6: e25787.
36. Patnaik SK, Kannisto E, Knudsen S, Yendamuri S, (2010) Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res 70: 36-45.
37. Ventura A, Jacks T, (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586-591.
38. Lee Y, Ahn C, Han J, Choi H, Kim J, et al. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419.
39. Grelier G, Voirin N, Ay AS, Cox DG, Chabaud S, et al. (2009) Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. Br J Cancer 101: 673-683.
40. Sugito N, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, et al. (2006) RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin Cancer Res 12: 7322-7328.
41. Chiosea S, Jelezcova E, Chandran U, Luo J, Mantha G, et al. (2007) Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res 67: 2345-2350.
42. Faber C, Horst D, Hlubek F, Kirchner T, (2011) Overexpression of Dicer predicts poor survival in colorectal cancer. Eur J Cancer 47: 1414-1419.
43. Mackay F, Browning JL, (2002) BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2: 465-475.
44. Mackay F, Leung H, (2006) The role of the BAFF/APRIL system on T cell function. Semin Immunol 18: 284-289.
45. Novak AJ, Grote DM, Ziesmer SC, Kline MP, Manske MK, et al. (2006) Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders. J Clin Oncol 24: 983-987.